Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 601–700 of 1,007
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 59
Ahumada-Castro, U., Bustos, G., Silva-Pavez, E., Puebla-Huerta, A., Lovy, A., & Cárdenas, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.629522 · Cited by 62
“IP3R2 is expressed in cardiac muscle, as well as liver, kidney, and other epithelial tissues (Klar et al., 2014), while IP3R3 is expressed in endothelial cells, testis, endocrine and exocrine pancreas, spleen, gastrointestinal tract, and thymus (De Smedt et al., 1997).”
BackgroundJohnston, K., Pachnis, P., Tasdogan, A., Faubert, B., Zacharias, L. G., Vu, H., Rodgers-Augustyniak, L. A., Johnson, A., Huang, F., Ricciardo, S., et al. (2021) · Med · doi:10.1016/j.medj.2021.01.002 · Cited by 53
Self-citationPhase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
Anderson, R. G., Miller, L. D., Isom, S. P., Chou, J. W., Pladna, K. M., Schramm, N. J., Ellis, L. R., Howard, D. S., Bhave, R. R., Manuel, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29039-4 · Cited by 53
He, Q., Yang, C., Xiang, Z., Huang, G., Wu, H., Chen, T., Dou, R., Song, J., Han, L., Song, T., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05436-x · Cited by 48
“Metabolic reprogramming is a characteristic phenotype of cancers that supports specific demands for energy, biosynthesis, and redox maintenance [8].”
BackgroundJin, W., Zhang, Y., Zhao, Z., & Gao, M. (2024) · Theranostics · doi:10.7150/thno.93962 · Cited by 54
The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer
Turan, M. P., Aebersold, D. M., Zimmer, Y., & Medová, M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0798-9 · Cited by 52
“The so-called Warburg effect is nowadays considered a major hallmark of cancer and numerous studies have been repeatedly reporting that various metabolic pathways appear to be distinctive in individual tumour cells [3, 4].”
BackgroundHughey, C. C., Trefts, E., Bracy, D. P., James, F. D., Donahue, E. P., & Wasserman, D. H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002568 · Cited by 50
“In addition to changes in SAM-mediated transmethylation, a hallmark of cancer is metabolic reprogramming, which refers to the enhanced or suppressed flux of nutrients through metabolic pathways as a result of mutations and/or other factors (10).”
BackgroundTargeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer
Shan, Y., Gao, Y., Jin, W., Fan, M., Wang, Y., Gu, Y., Shan, C., Sun, L., Li, X., Yu, B., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1832-6 · Cited by 52
Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma
Chattopadhyay, C., Oba, J., Roszik, J., Marszalek, J. R., Chen, K., Qi, Y., Eterovic, K. A., Robertson, A. G., Burks, J. K., McCannel, T. A., et al. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-28082 · Cited by 54
“Specifically, cancer cells show remarkable metabolic reprogramming through alterations in the tricarboxylic acid (TCA) cycle and/or oxidative phosphorylation (OxPhos) within mitochondria.(6) The enzyme succinate dehydrogenase A”
BackgroundPFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells
Özcan, S. C., Bozkurt, A. S., Altunok, T. H., Akkoç, A., Güzel, S., Güler, S., Imbert-Fernandez, Y., Muchut, R. J., Iglesias, A. Á., Gurpinar, Y., et al. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03751-5 · Cited by 53
Han, A., Purwin, T. J., Bechtel, N., Liao, C., Chua, V. Y. L., Seifert, E. L., Sato, T., Schug, Z. T., Speicher, D. W., Harbour, J. W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01554-y · Cited by 52
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer
Saggese, P., Sellitto, A., Martinez, C. A., Giurato, G., Nassa, G., Rizzo, F. M., Tarallo, R., & Scafoglio, C. (2020) · Cancers · doi:10.3390/cancers12123788 · Cited by 51
“The link between metabolism and epigenetics is mainly due to the fact that many chromatin-modifying enzymes require a specific metabolite to function [63,64]: acetyl-CoA provides the substrate for histone acetylation; methyl-transferases require s-adenosyl-methionine as methyl donor, relying on one-carbon metabolism;…”
BackgroundWang, Q., Liu, M., Bu, J., Deng, J., Jiang, B., Jiang, L., & He, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118925 · Cited by 50
Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease
Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 53
The emerging relationship between metabolism and DNA repair
Cucchi, D., Gibson, A., & Martin, S. A. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1912889 · Cited by 57
“Identifying the unique metabolic dependencies of specific cancer cells, may enable the noninvasive recognition of tumors, making it possible to directly target their essential pathways in order to prevent tumor progression [13,104,105].”
BackgroundLuo, J., Wang, H., Wang, L., Wang, G., Yao, Y., Xie, K., Li, X., Xu, L., Shen, Y., & Ren, B. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.022 · Cited by 54
“Glucose is the major energy source to support tumor growth and can also provide a carbon source for biosynthetic reactions.(1) Cancer cells exhibit dramatic aberration of glucose metabolism, displaying activation of glycolysis despite the presence of oxygen, also known as the “Warburg effect.”
BackgroundMitochondrial Transport in Glycolysis and Gluconeogenesis: Achievements and Perspectives
Passarella, S., Schurr, A., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312620 · Cited by 53
Jung, M., Lee, K., Im, Y., Seok, S. H., Chung, H., Kim, D.-Y., Han, D., Lee, C. H., Hwang, E. H., Park, S. Y., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13209 · Cited by 56
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
Abdelmoneim, M., Aboalela, M. A., Naoe, Y., Matsumura, S., Eissa, I. R., Bustos‐Villalobos, I., Sibal, P. A., Takido, Y., Kodera, Y., & Kasuya, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713353 · Cited by 51
“However, the immune-infiltrated immune cells may undergo metabolic reprogramming to adapt to the nutrient-deprived and immunosuppressive conditions [6].”
BackgroundMitochondrial DNA damage, repair, and replacement in cancer
Vodička, P., Vodenková, S., Danesova, N., Vodičková, L., Zobalová, R., Tomášová, K., Boukalová, Š., Berridge, M. V., & Neužil, J. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.09.010 · Cited by 57
Tang, Y., Huang, Y., Li, J., Qin, S., Xu, Y., An, T., Liu, C.-C., Wang, Q., & Zheng, L. (2018) · BMC Genomics · doi:10.1186/s12864-018-5143-6 · Cited by 48
Martin, S. D., & McGee, S. L. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0207-x · Cited by 48
Combination Therapy with Vitamin C Could Eradicate Cancer Stem Cells
Satheesh, N. J., Samuel, S. M., & Büsselberg, D. (2020) · Biomolecules · doi:10.3390/biom10010079 · Cited by 54
Oncometabolites: A new insight for oncology
Khatami, F., Aghamir, S. M. K., & Tavangar, S. M. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.873 · Cited by 53
“Finding the metabolic transformation apparatus can offer opportunities to recognize tumor tissue noninvasively, tumor behavior, or even stopping the tumor progression by blocking essential pathways (DeBerardinis & Chandel, 2016).”
BackgroundAutophagy and the Lysosomal System in Cancer
Kumar, S. G., Sánchez‐Álvarez, M., Lolo, F., Trionfetti, F., Strippoli, R., & Cordani, M. (2021) · Cells · doi:10.3390/cells10102752 · Cited by 51
“Due to the relevance of autophagy and the lysosome system in cancer biology, their modulation by drugs is a current target in cancer therapy [186,187].”
BackgroundLuby, A., & Alves‐Guerra, M. (2021) · Cancers · doi:10.3390/cancers13235912 · Cited by 54
Advances in measuring cancer cell metabolism with subcellular resolution
Ruiz‐Rodado, V., Lita, A., & Larion, M. (2022) · Nature Methods · doi:10.1038/s41592-022-01572-6 · Cited by 54
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 56
“However, a metabolic shift occurs in the nutrient-deprived state, wherein the cells activate different catabolic pathways that can supply the required glycolytic and TCA cycle intermediates for energy production (Figure 1) (8).”
BackgroundGharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 65
Shi, X., Tasdogan, A., Huang, F., Hu, Z., Morrison, S. J., & DeBerardinis, R. J. (2017) · Science Advances · doi:10.1126/sciadv.aao5268 · Cited by 47
“DISCUSSION Metabolic reprogramming is a hallmark of cancer and a potentially powerful indicator of the biochemical impact of a broad array of biological features in malignant tissue (15, 32).”
BackgroundSelf-citationCardone, R. A., Alfarouk, K. O., Elliott, R. L., Alqahtani, S. S., Ahmed, S. B. M., Aljarbou, A. N., Greco, M. R., Cannone, S., & Reshkin, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153694 · Cited by 49
“In this way, cytosolic pH would regulate the cells’ metabolic balance as a rheostat, as described in the general scheme imagined by DeBerardinis and Chandel [33], where instead of the usual on or off ‘switch’ between glycolysis and OxPHOS, they hypothesized the existence of a continuum between the two but did not have…”
BackgroundCancer Etiology: A Metabolic Disease Originating from Life’s Major Evolutionary Transition?
Poljšak, B., Kovač, V., Dahmane, R. G., Levec, T., & Starc, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7831952 · Cited by 51
“Anabolic pathways that advance growth are stimulated in cancer by means of tumorigenic mutations, especially PI3K-mTOR signaling [224].”
BackgroundThe multi-faceted functioning portrait of LRF/ZBTB7A
Constantinou, C., Σπέλλα, Μ., Chondrou, V., Patrinos, G. P., Papachatzopoulou, A., & Sgourou, A. (2019) · Human Genomics · doi:10.1186/s40246-019-0252-0 · Cited by 49
Bisag, A., Bucci, C., Coluccelli, S., Girolimetti, G., Laurita, R., Iaco, P. D., Perrone, A. M., Gherardi, M., Marchio, L., Porcelli, A. M., et al. (2020) · Cancers · doi:10.3390/cancers12020476 · Cited by 47
“One such difference has been shown to be the capacity of cancer cells to withstand the oxidative stress they come to face due to their metabolic rewiring, their high proliferation rate, and to the microenvironment conditions that quickly build up around a progressing tumor mass [33,40].”
BackgroundShaping of Dendritic Cell Function by the Metabolic Micro-Environment
Brombacher, E. C., & Everts, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00555 · Cited by 46
“Finally, malignancies are often characterized by unusually high concentrations of extracellular ATP and adenosine, hypoxia and by large quantities of ROS in poorly vascularized regions (52, 55).”
BackgroundIdentification of lipidomic profiles associated with drug-resistant prostate cancer cells
Ingram, L. M., Finnerty, M. C., Mansoura, M., Chou, C.-W., & Cummings, B. S. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01437-5 · Cited by 42
Introduction to mathematical oncology
Stadtländer, C. T. K. ‐. (2016) · Journal of Biological Dynamics · doi:10.1080/17513758.2016.1224937 · Cited by 47
Metabolic reprogramming in type 2 diabetes and the development of breast cancer
Martin, S. D., & McGee, S. L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0037 · Cited by 49
Qiu, R., Zhong, Y., Li, Q., Li, Y., & Fan, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.693215 · Cited by 46
“After metabolic reprogramming, tumors tend to gain energy through glycolysis rather than oxidative phosphorylation (OXPHOS) even under aerobic conditions (DeBerardinis and Chandel, 2016), which is called Warburg effect.”
BackgroundSLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia
Wei, Y., Huang, Y.-H., Skopelitis, D. S., Iyer, S. V., Costa, A. S. H., Yang, Z., Kramer, M., Adelman, E. R., Klingbeil, O., Demerdash, O. E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1849 · Cited by 53
“Depletion of sgRNAs Kinase (481) Glycosyltransferase (345) GPCR (771) lon channel (324) Membrane (1,103) Chromatin regulator (542) Transcription factor (1,426)”
BackgroundSebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Raffay, R. E., Cervi, C., Krencz, I., Zsiros, V., Jeney, A., & Petővári, G. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10006-2 · Cited by 50
Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?
Wackerhage, H., Vechetti, I. J., Baumert, P., Gehlert, S., Becker, L., Jaspers, R. T., & de Angelis, M. H. (2022) · Sports Medicine · doi:10.1007/s40279-022-01676-1 · Cited by 45
“For further information, for example, on substrate synthesis for epigenetic modification, see DeBerardinis and Chandel [5].”
BackgroundMethodInfluentialThe hexokinase “HKDC1” interaction with the mitochondria is essential for liver cancer progression
Khan, M. W., Terry, A. R., Priyadarshini, M., Ilievski, V., Farooq, Z., Guzman, G., Córdoba‐Chacón, J., Ben‐Sahra, I., Wicksteed, B. L., & Layden, B. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04999-z · Cited by 58
“One possible target is the phenomenon of “metabolic reprogramming” where cancer cells have an over-dependency on glucose with dysregulated glucose metabolism that can be therapeutically targeted [6, 7].”
Insights into molecular mechanisms of chemotherapy resistance in cancer
Kar, A., Agarwal, S., Singh, A., Bajaj, A., & Dasgupta, U. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.101901 · Cited by 52
“Such alterations bring forth metabolic reprogramming to fulfill the bioenergetic, biosynthetic, and redox requirements [16,17].”
BackgroundlncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Bhat, A. A., Afzal, M., Moglad, E. H. O., Thapa, R., Ali, H., Almalki, W. H., Kazmi, I. A., Alzarea, S. I., Gupta, G., & Subramaniyan, V. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01491-0 · Cited by 54
“The defining feature of cancer cells is the presence of altered metabolic characteristics, distinct from those of normal cells, allowing Page 12 of 24 them to out-compete normal cells in the harsh and often nutrient-poor conditions of tumors [235, 236].”
BackgroundEpigenetic changes in fibroblasts drive cancer metabolism and differentiation
Mishra, R., Haldar, S., Suchanti, S., & Bhowmick, N. A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0347 · Cited by 48
“…from oncogenic Ras activation, phosphatidylinositol 3-kinase (PI3-kinase) and phosphatase and tensin homolog (PTEN) mutations found in cancer (Chalhoub & Baker 2009) may also potentiate macropinocytosis as an adaptation to limiting nutrient availability (DeBerardinis & Chandel 2016, Cluntun et al.”
BackgroundInfluentialRescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 50
“In addition, the genetic ablation of LDH-A has been observed to delay the progression of myeloid leukemia [105].”
BackgroundTRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
Zeinabad, H. A., & Szegezdi, É. (2022) · Cancers · doi:10.3390/cancers14205125 · Cited by 50
“In the presence of ferrous or cuprous ions, H2O2 can be converted into OH• through the Fenton reaction [269,273].”
BackgroundLactate-related metabolic reprogramming and immune regulation in colorectal cancer
Sun, Q., Wu, J., Zhu, G., Li, T., Zhu, X., Ni, B., Xu, B., Ma, X., & Li, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1089918 · Cited by 61
““Metabolic reprogramming” is regulated by oncogenic signaling and transcriptional networks to alter the metabolic patterns of glucose, amino acids, lipids, and nucleic acids through processes such as aerobic glycolysis, glutamine catabolism, macromolecular synthesis, and nuclear acid homeostasis (4, 9).”
BackgroundRedox regulation of cancer stem cells: Biology and therapeutic implications
Du, M., Zhang, J., Wicha, M. S., & Luo, M. (2024) · MedComm – Oncology · doi:10.1002/mog2.70005 · Cited by 57
The receptor for advanced glycation end products: A fuel to pancreatic cancer
Shahab, U., Ahmad, M. K., Mahdi, A. A., Waseem, M., Arif, B., Moinuddin, M., & Ahmad, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.010 · Cited by 47
“There is an utilitarian NF-κB restricting site in the proximal promoter of RAGE which has been appeared to be an immediate gene of NF-κB signalling [19].”
BackgroundMetabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
Ciavardelli, D., Bellomo, M., Consalvo, A., Crescimanno, C., & Vella, V. (2017) · BioMed Research International · doi:10.1155/2017/2545031 · Cited by 48
“Furthermore, several recent evidences show that the metabolic heterogeneity of solid tumors is associated with the metabolic difference not only between the tumor stroma and cancer cells but also between cancer cells that grow under nutrient and oxygen-replete or hypoxic and nutrient starved conditions [89, 90].”
BackgroundŽdralević, M., Marchiq, I., de Padua, M. M. C., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00313 · Cited by 52
Ramirez‐Peña, E., Arnold, J. M., Shivakumar, V., Joseph, R., Vijay, G. V., den Hollander, P., Bhangre, N., Allegakoen, P., Prasad, R., Conley, Z. C., et al. (2019) · Cancers · doi:10.3390/cancers11101610 · Cited by 46
“Highly proliferative tumors consume glucose and amino acids, including glutamine, to sustain the metabolic demands that support biomass production [1].”
BackgroundXie, Y., Gao, W., Wu, Q., Yao, X., Jiang, Z., Wang, Y., Wang, W., Li, W., Hussain, S., Liu, L., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104934 · Cited by 50
Chong, Y. C., Toh, T. B., Chan, Z., Lin, Q. X. X., Thng, D. K. H., Hooi, L., Ding, Z., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1559 · Cited by 53
“Elevated energy consumption of tumor cells to support rapid proliferation necessitates the integration of various metabolic processes to sustain high levels of DNA replication and RNA production.(6) In this study, we found that HCCs up-regulate enzymes involved in purine metabolism.”
BackgroundInfluentialThe deubiquitinase JOSD2 is a positive regulator of glucose metabolism
Krassikova, L., Zhang, B., Nagarajan, D., Queiroz, A. L., Kacal, M., Samakidis, E., Vakifahmetoglu-Norberg, H., & Norberg, E. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00639-1 · Cited by 47
The Impact of Mitochondrial Fission-Stimulated ROS Production on Pro-Apoptotic Chemotherapy
Ježek, J., Cooper, K. F., & Strich, R. (2021) · Biology · doi:10.3390/biology10010033 · Cited by 51
“Increased levels of ROS as a result of metabolic rewiring are characteristic for many tumor types as they are thought to promote proliferation and cancer cell survival during tumorigenesis [8].”
BackgroundInfluentialIkari, R., Mukaisho, K., Kageyama, S., Nagasawa, M., Kubota, S., Nakayama, T., Murakami, S., Taniura, N., Tanaka, H., Kushima, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041805 · Cited by 50
“Glutamine is an oxidative substrate for the TCA cycle and a starting material for the synthesis of macromolecules [19].”
BackgroundFlexibility and Adaptation of Cancer Cells in a Heterogenous Metabolic Microenvironment
Bluemel, G., Mondal, A., & Leithner, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031476 · Cited by 52
“In fact, both glycolysis and oxidative phosphorylation (OXPHOS) are utilized in cancer cells to optimize cancer cell metabolism for unlimited growth [36].”
BackgroundInfluentialPodder, A., Murali, V. P., Deepika, S., Dhamija, A., Biswas, S., Maiti, K. K., & Bhuniya, S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02049 · Cited by 44
Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
Chhipa, A. S., & Patel, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119694 · Cited by 46
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer
Ferrarini, I., Louie, A. D., Zhou, L., & El‐Deiry, W. S. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0962 · Cited by 49
“Even if a peculiar metabolic reliance may occur in specific cell types, OXPHOS and glycolysis usually cooperate to make cancer cells metabolically plastic, a kind of paradigm in cancer biology accounting for the failure of some targeted agents when administered as monotherapy (15).”
Tunneling Nanotubes Facilitate Intercellular Protein Transfer and Cell Networks Function
Turos-Korgul, L., Kolba, M. D., Chrościcki, P., Zieminska, A., & Piwocka, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.915117 · Cited by 47
“mitochondria reprograming to supply anabolic pathways to and support rapid proliferation (DeBerardinis and Chandel, 2016).”
BackgroundWang, T., Sun, F., Li, C., Nan, P., Song, Y., Wan, X., Mo, H., Wang, J., Zhou, Y., Guo, Y., et al. (2023) · Advanced Science · doi:10.1002/advs.202300756 · Cited by 51
Zhou, Y., Guo, Y., Ran, M., Shan, W., Granchi, C., Giovannetti, E., Minutolo, F., Peters, G. J., & Tam, K. Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216425 · Cited by 53
Hamanaka, R. B., & Mutlu, G. M. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.020 · Cited by 44
“This aerobic glycolysis provides cells with metabolic intermediates used in the synthesis of nucleotides, amino acids, and fatty cids that are required for duplication of cellular biomass during proliferation (DeBerardinis and Chandel, 2016).”
BackgroundLeri, M., Ramazzotti, M., Vasarri, M., Peri, S., Barletta, E., Pretti, C., & Degl’Innocenti, D. (2018) · Marine Drugs · doi:10.3390/md16040137 · Cited by 48
“Autophagy process leads cells to digest parts and components of their own cytoplasm to overcome intracellular or environmental stress conditions, as nutrient deprivation or hypoxia [6,7].”
BackgroundMagnetic resonance imaging of cancer metabolism with hyperpolarized 13C-labeled cell metabolites
Hesketh, R. L., & Brindle, K. M. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.03.004 · Cited by 48
Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies
Vela, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00547 · Cited by 48
“Creating an environment that suits these needs means that cancer cells have to adapt manifold; they have to be able to secure energy for their metabolism in hypoxic conditions, but also they should be able to increase the transport of metabolites and micronutrients, even by “stealing” from their “neighborhood” (1).”
BackgroundTargeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Dahl, E. S., Buj, R., Leon, K. E., Newell, J. M., Kawasawa, Y. I., Bitler, B. G., Snyder, N. W., & Aird, K. M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1233 · Cited by 51
MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer
Liu, F., Xiao, X., Ou, X., Gao, G., Bazhabayi, M., & Zhang, K. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_282_19 · Cited by 44
“BACH1 can reprogram metabolic pathways by targeting mitochondrial metabolism.([4,6]) In addition, BACH1 expression was upregulated in the tumors of patients with TNBC.”
BackgroundChu, J., Niu, X., Chang, J., Shao, M., Peng, L., Xi, Y., Lin, A., Wang, C., Cui, Q., Luo, Y., et al. (2020) · Theranostics · doi:10.7150/thno.41427 · Cited by 47
“Metabolic remodeling such as glutamine addiction is common in many types of human cancer and has been associated with malignant phenotypes [25-27], but the underlying causes remain poorly understood.”
BackgroundAntiproliferative Effect of Acridine Chalcone Is Mediated by Induction of Oxidative Stress
Takáč, P., Kello, M., Vilková, M., Vašková, J., Michalková, R., Mojžišová, G., & Mojžíš, J. (2020) · Biomolecules · doi:10.3390/biom10020345 · Cited by 46
“It should be noted that cancer cells, due to higher concentration of some ions and greater metabolic activity [48,49], are more susceptible to oxidative stress in comparison with non-cancer cells, and this phenomenon explains the higher sensitivity of cancer cells to pro-oxidants [50].”
BackgroundOrlicka-Płocka, M., Gurda, D., Fedoruk‐Wyszomirska, A., & Wyszko, E. (2020) · APOPTOSIS · doi:10.1007/s10495-020-01637-x · Cited by 46
Tonry, C. L., Finn, S. P., Armstrong, J., & Pennington, S. R. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09305-7 · Cited by 52
Tumor microenvironment metabolites directing T cell differentiation and function
Liu, X., Hoft, D. F., & Peng, G. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.12.004 · Cited by 48
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
Yang, T., You, C., Meng, S., Lai, Z., Ai, W., & Zhang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935205 · Cited by 50
The mTORC1-SLC4A7 axis stimulates bicarbonate import to enhance de novo nucleotide synthesis
Ali, E. S., Lipońska, A., O’Hara, B. P., Amici, D. R., Torno, M. D., Gao, P., Asara, J. M., Yap, M.-N. F., Mendillo, M. L., & Ben‐Sahra, I. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.008 · Cited by 48
Choi, K. M., Kim, J. J., Yoo, J., Kim, K. S., Gu, Y., Eom, J., Jeong, H., Kim, K., Nam, K. T., Park, Y. S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157302 · Cited by 45
“190 In solid cancers, cancer cells reside in a nutrient- and oxygen-poor environment (34) and under the 191 influence of cytokines including IFN-γ produced from immune cells (35).”
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma
Saggese, P., Pandey, A., Alcaraz, M., Fung, E., Hall, A., Yanagawa, J., Rodriguez, E. F., Grogan, T., Giurato, G., Nassa, G., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1148 · Cited by 51
“Rewiring of energy metabolism is a hallmark of cancer, and the increased dependency on glucose is a common characteristic of cancer cells (1, 2).”
Dietary and metabolic effects on intestinal stem cells in health and disease
Shay, J. E. S., & Yilmaz, Ö. H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00980-7 · Cited by 64
O-GlcNAcylation and chromatin remodeling in mammals: an up-to-date overview
Leturcq, M., Lefebvre, T., & Vercoutter‐Edouart, A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160388 · Cited by 43
Zhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 45
“Non-essential amino acids serve as precursors to purine and pyrimidine synthesis and methyl groups are obtained from the carbon (1C)/folate pool [54].”
BackgroundStrickaert, A., Corbet, C., Spinette, S. A., Craciun, L., Dom, G., Andry, G., Larsimont, D., Wattiez, R., Dumont, J. E., Féron, O., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0435 · Cited by 51
“Enhanced glucose metabolism was validated by the demonstration of overexpression of glucose transporters 1 and 3 (GLUT1 and GLUT3) and hexokinase 2 (HK2) in BRAF - mutated PTC (17,18).”
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
Joshi, M., Stoykova, G. E., Salzmann‐Sullivan, M., Dzieciątkowska, M., Liebman, L. N., Deep, G., & Schlaepfer, I. R. (2019) · Cells · doi:10.3390/cells8101115 · Cited by 44
“Since CPT1A is not an oncogene, but a liver enzyme also abundant in epithelial cancers [36], finding its role in cancer has not been intuitive, especially since most cancers have a strong dependency on glucose and rely on the Warburg effect [37].”
BackgroundWu, Z., Han, X., Tan, G., Zhu, Q., Chen, H., Xia, Y., Gong, J., Wang, Z., Wang, Y., & Yan, J. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s224062 · Cited by 45
“meet the requirement of cell proliferation.(3) In addition, the product of tumor glycolysis can acidify the microenvironment around tumor tissue and help tumor cells escape the surveillance of the immune system and give rise to tumor cell invasion and metastasis.”
BackgroundNikolaou, S., & Machesky, L. M. (2020) · The Journal of Pathology · doi:10.1002/path.5395 · Cited by 47
“Cancer cells readily respond to the stress of starvation by ramping up nutrient uptake pathways, utilising alternative sources of energy, and rewiring their metabolism (reviewed in [64,65]).”
BackgroundMetabolic Determinants of Cardiomyocyte Proliferation
Mohamed, T., Abouleisa, R., & Hill, B. G. (2022) · Stem Cells · doi:10.1093/stmcls/sxac016 · Cited by 43
A pan-cancer metabolic atlas of the tumor microenvironment
Rohatgi, N., Ghoshdastider, U., Baruah, P., Kulshrestha, T., & Skanderup, A. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110800 · Cited by 46
Ovarian Cancer: A Landscape of Mitochondria with Emphasis on Mitochondrial Dynamics
Rasmo, D. D., Cormio, A., Cormio, G., & Signorile, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021224 · Cited by 52
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
Chen, T., Xie, S., Cheng, J., Zhao, Q. L., Wu, H., Jiang, P., & Du, W. (2024) · Nature Communications · doi:10.1038/s41467-024-44772-8 · Cited by 52
“Importantly, glycolysis is directly coupled with mitochondrialmetabolismsuchastheTCAcycle,whichactsasamajor process supporting the energetic and biosynthetic demands of proliferating cancer cells 21,22 .”
The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer
Seyfried, T. N., Lee, D. C., Duraj, T., Ta, N. L., Mukherjee, P., Kiebish, M. A., Arismendi-Morillo, G., & Chinopoulos, C. (2025) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-025-10059-w · Cited by 52
“…unimpaired in cancer and that gene-linked abnormalities in the regulation of glycolysis were mostly responsible for the growth of cancer cells (Zu and Guppy 2004; Koppenol et al. 2011; Moreno-Sanchez et al. 2014; DeBerardinis and Chandel 2016; Vander Heiden et al. 2009; Liberti and Locasale 2016).”
Jadhav, K., Abhang, A., Kole, E. B., Gadade, D. D., Dusane, A., Iyer, A., Sharma, A., Rout, S. K., Gholap, A. D., Naik, J., et al. (2025) · Bioengineering · doi:10.3390/bioengineering12050481 · Cited by 59
“These include the dysregulation of translational machinery [72], alterations in epigenetic regulatory mechanisms [73], and the overproduction of enzymes crucial for their survival and evasion of the body’s natural defense mechanisms against uncontrolled proliferation [74].”
Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors
Jonnalagadda, S., Jonnalagadda, S. K., Ronayne, C. T., Nelson, G. L., Solano, L. N., Rumbley, J. N., Holy, J. M., Mereddy, V. R., & Drewes, L. R. (2019) · Oncotarget · doi:10.18632/oncotarget.26760 · Cited by 47
Aquaporin-7 Regulates the Response to Cellular Stress in Breast Cancer
Dai, C., Charlestin, V., Wang, M., Walker, Z. T., Miranda-Vergara, M. C., Facchine, B. A., Wu, J., Kaliney, W. J., Dovic̀hi, N. J., Li, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2269 · Cited by 51
“Increased ROS in cancer cells could tip the balance towards cell death, whereas the same ROS level increase in normal cells may actually boost proliferation (1).”
BackgroundThe role of the glutamine transporter ASCT2 in antineoplastic therapy
Teixeira, E., Silva, C., & Martel, F. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04218-6 · Cited by 51
Maitland, M. E. R., Kuljanin, M., Wang, X., Lajoie, G., & Schild‐Poulter, C. (2021) · The FASEB Journal · doi:10.1096/fj.202100664r · Cited by 39
Hisam, N. S. N., Ugusman, A., Rajab, N. F., Ahmad, M. F., Fenech, M. F., Liew, S. L., & Anuar, N. N. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091353 · Cited by 47
“Several metabolic alterations are associated with cancer, including the elevation of nitrogen demand, deregulated uptake of nutrients such as glucose and amino acids, and changes in metabolite-driven gene regulation [10,11].”
Background
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.